On August 5, 2019, Oramed Pharmaceuticals Inc. appointed Mr. Joshua Hexter, to serve as Chief Operating & Business Officer, effective September 19, 2019. Prior to his appointment, Mr. Hexter served as Chief Business Officer at BrainsWay Ltd. from 2018 to 2019, commercial stage medical device company focused on the development and sale of non-invasive neuromodulation products. From 2013 to 2018, Mr. Hexter served as Chief Operating Officer and VP Business Development of the Company and from 2007 to 2013, Mr. Hexter was a Director or Executive Director of BioLineRx Ltd. Prior to his employment with BioLineRx, Mr. Hexter was a member of the board of directors and Chief Executive Officer of Biosensor Systems Design Inc., a company developing market-driven biosensors. Mr. Hexter holds a bachelor's degree from the University of Wisconsin and a master's degree in management from Boston University. Mr. Hexter will be employed by the company pursuant to an employment agreement with the Company's wholly-owned Israeli subsidiary, Oramed Ltd.